Torthaí cuardaigh - Steve Rosenfeld
- 1 - 3 toradh as 3 á dtaispeáint
-
1
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma de réir Surasak Phuphanich, Jeffrey G. Supko, Kathryn A. Carson, Stuart A. Grossman, Burt Nabors, Tom Mikkelsen, Glenn J. Lesser, Steve Rosenfeld, Serena Desideri, Jeffrey J. Olson
Foilsithe / Cruthaithe 2010Artigo -
2
The unique insert in myosin VI is a structural calcium–calmodulin binding site de réir Amel Bahloul, Guillaume Chevreux, Amber L. Wells, Davy Martin, Jocelyn K. Nolt, Zhaohui Yang, Li-Qiong Chen, Noëlle Potier, Alain Van Dorsselaer, Steve Rosenfeld, Anne Houdusse, H. Lee Sweeney
Foilsithe / Cruthaithe 2004Artigo -
3
A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma de réir David A. Reardon, Morris D. Groves, Patrick Y. Wen, Burt Nabors, Tom Mikkelsen, Steve Rosenfeld, Jeffrey J. Raizer, Jorge Barriuso, Roger E. McLendon, A. Benjamin Suttle, Bo Ma, C. Martin Curtis, Mohammed M. Dar, Johann S. de Bono
Foilsithe / Cruthaithe 2013Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biochemistry
Biology
Cancer research
Glioma
Internal medicine
Medicine
Oncology
Pharmacology
Binding site
Biophysics
Bortezomib
Breast cancer
Calcium
Calcium-binding protein
Calmodulin
Cancer
Chemistry
Chemotherapy
Clinical trial
EF hand
Enzyme
Gastroenterology
Lapatinib
Multiple myeloma
Myosin
Myosin light-chain kinase
Organic chemistry
PI3K/AKT/mTOR pathway
PTEN
Pazopanib